chrX-140784057-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000648200.2(LINC00632):n.12076C>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000364 in 1,098,070 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000648200.2 non_coding_transcript_exon
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDR1 | XR_006652813.2 | n.9156G>T | non_coding_transcript_exon_variant | 1/1 | ||||
LINC00632 | NR_173144.1 | n.345-6945C>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LINC00632 | ENST00000648200.2 | n.12076C>A | non_coding_transcript_exon_variant | 5/5 | ||||||
CDR1 | ENST00000674533.1 | n.310G>T | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD3 exomes AF: 0.00000546 AC: 1AN: 183086Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67630
GnomAD4 exome AF: 0.00000364 AC: 4AN: 1098070Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 1AN XY: 363456
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 02, 2022 | The c.310G>T (p.D104Y) alteration is located in exon 1 (coding exon 1) of the CDR1 gene. This alteration results from a G to T substitution at nucleotide position 310, causing the aspartic acid (D) at amino acid position 104 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at